On average, imaging costs per patient were almost 300% higher in the substance-use cohort, experts detailed in Academic Radiology. 

The proportion of women undergoing breast cancer imaging has dropped significantly from the peak seen between 2007 and 2010. 

UHC has labeled an IR service docs have been delivering for 9 years as “unproven and not medically necessary due to insufficient evidence of efficacy." 

The Siemens Magnetom scanner utilizes dedicated radiofrequency sodium coils and parallel transmit technology—a “stark” difference from older models

EMBOLIZE is a first-of-its-kind prospective, randomized control study on IR specialists' use of ovarian and pelvic vein embolization. 

The offering is from Ionic Health, which is based in São Paulo, Brazil, where the company has already tested the technology for three years. 

“With further tuning and validation, this pipeline may potentially add value in cancer screening, staging, diagnosis and prognosis," experts wrote in Cell Reports Medicine.  
 

“Surprisingly,” experts wrote in Nature Medicine, experience-based factors such as a physicians’ subspecialty or previous AI use failed to reliably predict the technology's impact.